Current status of genetics research in inflammatory bowel disease (original) (raw)

• Roth MP, Petersen GM, McElree C et al. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989; 97: 900–904.
  CAS PubMed Google Scholar
• Yang H, McElree C, Shanahan F et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993; 34: 517–524.
  CAS PubMed PubMed Central Google Scholar
• Orholm M, Munkholm P, Langholz E et al. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991; 324: 84–88.
  Article CAS PubMed Google Scholar
• Peeters M, Nevens H, Baert F et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996; 111: 597–603.
  CAS PubMed Google Scholar
• Satsangi J, Rosenberg W, Jewell DP . The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Eur J Gastroenterol Hepatol 1994; 6: 413–416.
  Google Scholar
• Laharie D, Debeugny S, Peeters M et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 2001; 120: 816–819.
  CAS PubMed Google Scholar
• Tysk C, Lindberg E, Jarnerot G et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 990–996.
  Article CAS PubMed PubMed Central Google Scholar
• Thompson NP, Driscoll R, Pounder RE et al. Genetic versus environment in inflammatory bowel disease: results of a British Twin Study. BMJ 1996; 312: 95–96.
  Article CAS PubMed PubMed Central Google Scholar
• Orholm M, Binder V, Sorensen TI, Rasmussen LP, Kyvik KO . Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000; 35: 1075–1081.
  Article CAS PubMed Google Scholar
• Halfvarson J, Bodin L, Tysk C et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124: 1767–1773.
  PubMed Google Scholar
• Vermeire S, Peeters M, Vlietinck R et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 2001; 7: 8–15.
  CAS PubMed Google Scholar
• Shanahan F, Duerr R, Rotter JI . Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992; 103: 456–461.
  CAS PubMed Google Scholar
• Bouma G, Crusius JB, Garcia-Gonzalez MA et al. Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol 1999; 115: 294–300.
  CAS PubMed PubMed Central Google Scholar
• Seibold F, Slametschka D, Gregor M et al. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994; 107: 532–536.
  CAS PubMed Google Scholar
• Sendid B, Quinton JF, Charrier G et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998; 93: 1306–1310.
  CAS PubMed Google Scholar
• Landers CJ, Cohavy O, Misra R et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002; 123: 689–699.
  CAS PubMed Google Scholar
• Mow WS, Vasiliauskas EA, Lin YC et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004; 126: 414–424.
  CAS PubMed Google Scholar
• Lodes MJ, Cong Y, Elson CO et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004; 113: 1296–1306.
  CAS PubMed PubMed Central Google Scholar
• The International HapMap Consortium. International HapMap Project. Nature 2003; 426: 789–796.
• Hugot JP, Laurent-Puig P, Gower-Rousseau C et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821–823.
  CAS PubMed Google Scholar
• Satsangi J, Parkes M, Louis E et al. Two-stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996; 14: 199–202.
  CAS PubMed Google Scholar
• Cho JH, Nicolae DL, Gold LH et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 1998; 95: 7502–7507.
  CAS PubMed PubMed Central Google Scholar
• Hampe J, Schreiber S, Shaw SH et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999; 64: 808–816.
  CAS PubMed PubMed Central Google Scholar
• Ma Y, Ohmen JD, Li Z et al. A genome wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis 1999; 5: 271–278.
  CAS PubMed Google Scholar
• Duerr RH, Barmada MM, Zhang L et al. High-Density Genome Scan in Crohn disease Shows Confirmed Linkage to Chromosome 14q11-12. Am J Hum Genet 2000; 66: 1857–1862.
  CAS PubMed PubMed Central Google Scholar
• Rioux JD, Silverberg MS, Daly MS et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863–1870.
  CAS PubMed PubMed Central Google Scholar
• Williams CN, Kocher K, Lander ES, Daly MJ, Rioux JD . Using a genome-wide scan and meta-analysis to identify a novel IBD locus and confirm previously identified IBD loci. Inflamm Bowel Dis 2002; 8: 375–381.
  PubMed Google Scholar
• Paavola-Sakki P, Ollikainen V, Helio T et al. Genome-wide search in Finnish families with inflammatory bowel disease provides evidence for novel susceptibility loci. Eur J Hum Genet 2003; 11: 112–120.
  CAS PubMed Google Scholar
• Vermeire S, Rutgeerts P, Van Steen K et al. Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. Gut 2004; 53: 980–986.
  CAS PubMed PubMed Central Google Scholar
• Barmada MM, Brant SR, Nicolae DL et al. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm Bowel Dis 2004; 10: 15–22.
  PubMed Google Scholar
• van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM . Genome Scan Meta-Analysis Group of the IBD International Genetics Consortium Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004; 13: 763–770.
  CAS PubMed Google Scholar
• Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603.
  CAS PubMed Google Scholar
• Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–606.
  CAS PubMed Google Scholar
• Hampe J, Cuthbert A, Croucher PJ et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925–1928.
  CAS PubMed Google Scholar
• Lesage S, Zouali H, Cezard JP et al. CARD15/NOD2 mutational analysis and genotype–phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845–857.
  CAS PubMed PubMed Central Google Scholar
• Rosenstiel P, Fantini M, Brautigam K et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124: 1001–1009.
  CAS PubMed Google Scholar
• Lala S, Ogura Y, Osborne C et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003; 125: 47–57.
  CAS PubMed Google Scholar
• Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK . CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003; 124: 993–1000.
  CAS PubMed Google Scholar
• Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G . Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001; 276: 4812–4818.
  CAS PubMed Google Scholar
• Gutierrez O, Pipaon C, Inohara N et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002; 277: 41701–41705.
  CAS PubMed Google Scholar
• Inohara N, Ogura Y, Fontalba A et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278: 5509–5512.
  CAS PubMed Google Scholar
• Kobayashi KS, Chamaillard M, Ogura Y et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731–734.
  CAS PubMed Google Scholar
• Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004; 53: 1658–1664.
  CAS PubMed PubMed Central Google Scholar
• Watanabe T, Kitani A, Murray PJ, Strober W . NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800–808.
  CAS PubMed Google Scholar
• Maeda S, Hsu LC, Liu H et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005; 307: 734–738.
  CAS PubMed Google Scholar
• Stoll M, Corneliussen B, Costello CM et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004; 36: 476–480.
  CAS PubMed Google Scholar
• Daly MJ, Pearce AV, Farwell L et al. Association of DLG5 R30Q variant with inflammatory bowel disease. Eur J Hum Genet 2005; 13: 835–839.
  CAS PubMed Google Scholar
• Noble CL, Nimmo ER, Drummond H et al. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Gut 2005; Apr 20 (Epub ahead of print).
• Torok HP, Glas J, Tonenchi L et al. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 2005; Jun 14 (Epub ahead of print).
• Vermeire S, Pierik M, Henckaerts L et al. Study on DLG5 and OCTN polymorphisms shows association of the OCTN TC risk haplotype with perianal and fistulizing Crohn's disease but not with susceptibility to IBD. Gastroenterol, in press.
• Peltekova VD, Wintle RF, Rubin LA et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36: 471–475.
  CAS PubMed Google Scholar
• Rioux JD, Daly MJ, Silverberg MS et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223–228.
  CAS PubMed Google Scholar
• Giallourakis C, Stoll M, Miller K et al. IBD5 is a general risk Factor for inflammatory bowel disease: replication of association with Crohn's disease and identification of a novel association with ulcerative colitis? Am J Hum Genet 2003; 73: 205–211.
  CAS PubMed PubMed Central Google Scholar
• Negoro K, McGovern DPB, Kinouchi Y et al. Analysis of the IBD5 locus and potential gene–gene interactions in Crohn's disease. Gut 2003; 52: 541–546.
  CAS PubMed PubMed Central Google Scholar
• Mirza MM, Fisher SA, King K et al. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am J Hum Genet 2003; 72: 1018–1022.
  CAS PubMed PubMed Central Google Scholar
• Mc Govern DPB, van Heel DA, Negoro K et al. Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. Am J Hum Genet 2003; 73: 1465–1466.
  CAS Google Scholar
• Gründemann D, Gorboulev V, Gambaryan S et al. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994; 372: 549–552.
  PubMed Google Scholar
• Lahjouji K, Mitchell GA, Qureshi IA . Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol Genet Metab 2001; 73: 287–297.
  CAS PubMed Google Scholar
• Tamai I, Yabuuchi H, Nezu J et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 1997; 419: 107–111.
  CAS PubMed Google Scholar
• Wu X, Prasad PD, Leibach FH et al. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 1998; 246: 589–595.
  CAS PubMed Google Scholar
• Roediger WE, Nance S . Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br J Exp 1986; 67: 773–782.
  CAS Google Scholar
• McGovern DP, Hysi P, Ahmad T et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 2005; 14: 1245–1250.
  CAS PubMed Google Scholar
• Zouali H, Lesage S, Merlin F et al. CARD4/NOD1 is not involved in inflammatory bowel disease. Gut 2003; 52: 71–74.
  CAS PubMed PubMed Central Google Scholar
• Toyoda H, Wang SJ, Yang HY et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104: 741–748.
  CAS PubMed Google Scholar
• Danze PM, Colombel JF, Jacquot S et al. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 1996; 39: 69–72.
  CAS PubMed PubMed Central Google Scholar
• Satsangi J, Welsh KI, Bunce M et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347: 1212–1217.
  CAS PubMed Google Scholar
• Stokkers PC, Reitsma PH, Tytgat GN et al. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999; 45: 395–401.
  CAS PubMed PubMed Central Google Scholar
• Franchimont D, Vermeire S, El Housni H et al. Deficient host-bacteria interactions in inflammatory bowel disease. The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004; 53: 987–992.
  CAS PubMed PubMed Central Google Scholar
• Lakatos PL, Lakatos L, Szalay F et al, Hungarian IBD Study Group. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype–genotype correlations. World J Gastroenterol 2005; 11: 1489–1495.
  CAS PubMed PubMed Central Google Scholar
• Gazouli M, Mantzaris G, Kotsinas A et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 2005; 11: 681–685.
  CAS PubMed PubMed Central Google Scholar
• Torok HP, Glas J, Tonenchi L et al. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 2004; 112: 85–91.
  CAS PubMed Google Scholar
• Oostenbrug LE, Drenth JP, de Jong DJ et al. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 567–575.
  PubMed Google Scholar
• Abreu MT, Taylor KD, Lin YC et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002; 123: 679–688.
  CAS PubMed Google Scholar
• Ahmad T, Armuzzi A, Bunce M et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002; 122: 854–866.
  CAS PubMed Google Scholar
• Cavanaugh JA, Adams KE, Quak EJ et al. CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann Hum Genet 2003; 67: 35–41.
  CAS PubMed Google Scholar
• Cuthbert AP, Fisher SA, Mirza MM et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122: 867–874.
  CAS PubMed Google Scholar
• Esters N, Pierik M, van Steen K et al. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am J Gastroenterol 2004; 99: 299–305.
  CAS PubMed Google Scholar
• Mendoza JL, Murillo LS, Fernandez L et al. Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease. Scand J Gastroenterol 2003; 38: 1235–1240.
  CAS PubMed Google Scholar
• Roussomoustakaki M, Koutroubakis I, Vardas EM et al. NOD2 insertion mutation in a Cretan Crohn's disease population. Gastroenterology 2003; 124: 272–273.
  PubMed Google Scholar
• Vermeire S, Wild G, Kocher K et al. CARD15 genetic variation in a Quebec population: prevalence, genotype–phenotype relationship, and haplotype structure. Am J Hum Genet 2002; 71: 74–83.
  CAS PubMed PubMed Central Google Scholar
• Helio T, Halme L, Lappalainen M et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003; 52: 558–562.
  CAS PubMed PubMed Central Google Scholar
• Bairead E, Harmon DL, Curtis AM et al. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet 2003; 11: 237–244.
  CAS PubMed Google Scholar
• Arnott ID, Nimmo ER, Drummond HE et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun 2004; 5: 417–425.
  CAS PubMed Google Scholar
• Inoue N, Tamura K, Kinouchi Y et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86–91.
  CAS PubMed Google Scholar
• Sugimura M, Kinouchi Y, Takahashi S et al. CARD15/NOD2 mutational analysis in Japanese patients with Crohn's disease. Clin Genet 2003; 63: 160–162.
  CAS PubMed Google Scholar
• Leong RWL, Armuzzi A, Ahmad T et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003; 17: 1465–1470.
  CAS PubMed Google Scholar
• Bonen DK, Niclolae DL, Moran T et al. Racial differences in Nod2 variation: characterization of Nod2 in African-Americans with Crohn ‘s disease. Gastroenterology 2002; 122 (Suppl): A-29.
  Google Scholar
• Hampe J, Grebe J, Nikolaus S et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a Cohort Study. Lancet 2002; 359: 1661–1665.
  CAS PubMed Google Scholar
• Holler E, Rogler G, Herfarth H et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004; 104: 889–894.
  CAS PubMed Google Scholar
• Armuzzi A, Ahmad T, Ling KL et al. Genotype–phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 2003; 52: 1133–1139.
  CAS PubMed PubMed Central Google Scholar
• Libioulle C, Thys J, Farnir F et al. Functional variants of Octn cation transporter gene are associated with perianal Crohn's disease. Gastroenterol Suppl 2005; 128: A445.
  Google Scholar
• Newman B, Gu X, Wintle R et al. A risk haplotype in the solute carrier family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 2005; 128: 260–269.
  CAS PubMed Google Scholar
• Roussomoustakaki M, Satsangi J, Welsh K et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997; 112: 1845–1853.
  CAS PubMed Google Scholar
• Orchard TR, Thiyagaraja S, Welsh KI et al. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000; 118: 274–278.
  CAS PubMed Google Scholar
• Orchard TR, Chua CN, Ahmad T et al. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 2002; 123: 714–718.
  PubMed Google Scholar
• Orchard TR, Wordsworth BP, Jewell DP . Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998; 42: 387–391.
  CAS PubMed PubMed Central Google Scholar
• Hoffmeyer S, Burk O, von Richter O et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473–3478.
  CAS PubMed PubMed Central Google Scholar
• Farrell RJ, Murphy A, Long A et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 2000; 118: 279–288.
  CAS PubMed Google Scholar
• Honda M, Orii F, Ayabe T et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 2000; 118: 859–866.
  CAS PubMed Google Scholar
• Weinshilboum RM, Sladek SL . Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651–662.
  CAS PubMed PubMed Central Google Scholar
• Yates CR, Krynetski EY, Loennechen T et al. Molecular diagnosis of thiopurine _S_-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126: 608–614.
  CAS PubMed Google Scholar
• Dubinsky MC, Lamothe S, Yang HY et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118: 705–713.
  CAS PubMed Google Scholar
• Cuffari C, Hunt S, Bayless T . Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut 2001; 48: 642–646.
  CAS PubMed PubMed Central Google Scholar
• Colombel JF, Ferrari N, Debuysere H et al. Genotypic analysis of thiopurine _S_-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 2000; 118: 1025–1030.
  CAS PubMed Google Scholar
• Dubinsky MC, Yang H, Hassard PV et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002; 122: 904–915.
  CAS PubMed Google Scholar
• Louis E, Vermeire S, Rutgeerts P et al. A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with −308 TNF gene polymorphism. Scand J Gastroenterol 2002; 37: 818–824.
  CAS PubMed Google Scholar
• Mascheretti S, Hampe J, Kuhbacher T et al. Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab. Pharmacogenom J 2002; 2: 127–136.
  CAS Google Scholar
• Pierik M, Vermeire S, Van Steen K et al. TNF-Alpha receptor 1 and 2 (TNFR1 and TNFR2) polymorphisms in IBD and their association with response to infliximab. Aliment Pharmacol Ther 2004; 20: 303–310.
  CAS PubMed Google Scholar
• Vermeire S, Louis E, Rutgeerts P et al Belgian Group of Infliximab Expanded Access Program and Fondation Jean Dausset CEPH, Paris, France. NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology 2002; 123: 106–111.
  CAS PubMed Google Scholar
• Mascheretti S, Hampe J, Croucher PJ et al. Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials. Pharmacogenetics 2002; 12: 509–515.
  CAS PubMed Google Scholar
• Louis E, El Ghoul Z, Vermeire S et al. Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther 2004; 19: 511–519.
  CAS PubMed Google Scholar
• Weng WK, Levy R . Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 2003; 21: 3940–3947.
  CAS PubMed Google Scholar
• Cartron G, Dacheux L, Salles G et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood 2002; 99: 754–758.
  CAS PubMed Google Scholar
• Hlavaty T, Pierik M, Joossens S et al. Genotype TT in the promoter region of apoptotic gene Fas ligand is associated with unfavorable clinical response to infliximab treatment in refractory luminal Crohn's disease. Aliment Pharmacol Ther (in press).